Position in WGS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,219,571
New position
Shares Held
34,562
first reported quarter
Ownership
0.116%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 88.0649267982177.ToString("F0")%
Shared 0.ToString("F0")%
None 11.935073201782304.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $58,272,910 across 13 Diagnostics & Research names. WGS ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PSNL |
Personalis, Inc.
|
2,183,572 | $13,909,353 | |
| 2 | ADPT |
Adaptive Biotechnologies Corp
|
931,522 | $12,929,525 | |
| 3 | CRL |
Charles River Laboratories International, Inc.
|
43,634 | $7,526,865 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
14,073 | $6,917,301 | |
| 5 | A |
Agilent Technologies, Inc.
|
41,202 | $4,696,203 | |
| 6 | DHR |
Danaher Corp /De/
|
14,638 | $2,775,364 | |
| 7 | WGS |
GeneDx Holdings Corp.
This page
|
34,562 | $2,219,571 | |
| 8 | VCYT |
Veracyte, Inc.
|
54,320 | $1,749,647 |
All Filings in WGS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,219,571 | 34,562 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||